Diagnos Inc.

Diagnos Inc.

September 27, 2010 10:00 ET

Union Securities Initiates Research Coverage on DIAGNOS

BROSSARD, QUEBEC, CANADA--(Marketwire - Sept. 27, 2010) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announced today that Union Securities released their initial research report on DIAGNOS last week.

Union Securities, an independent Canadian brokerage firm, initiated equity research coverage and published a report which contains a speculative buy rating and a target price of $0.75 per share.

Follow this link to view the complete version of the report.


Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment.

Forward-looking statements: Except for statement of historical fact, all statements in this news release, without limitation, regarding new projects, acquisitions, future plans and objectives are forward-looking statements which involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate; actual results and future events could differ materially from those anticipated in such statements.

For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

Contact Information

  • Diagnos Inc.
    Andre Larente
    1-877-678-8882 or 450-678-8882, ext.: 224